Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > Prizes > Prize Recipients > Franziska Michor

Franziska Michor

2015 Vilcek Prize for Creative Promise in Biomedical Science

Location

Cambridge, MA

Title

Professor of Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health

Area(s) of Research

Stem cell and regenerative biology

Education

Harvard University (PhD & MS); University of Vienna (BS, mathematics & molecular biology)

Country of Birth

Austria

Links to learn more about Franziska Michor's work
  • harvard.edu

Tags
Austria biology biomedical science data regenerative biology stem cell research
Share this page
Twitter Facebook LinkedIn

Franziska Michor stands leaning against the glass doors of an office space, dressed in jeans and a black sweater.

Franziska Michor, a professor at Dana-Farber Cancer Institute and Harvard School of Public Health, has used mathematical modeling to study the molecular subtleties of cancer progression and drug resistance. Her models have led to unconventional cancer treatment regimens that are now being tested in patients.

Michor’s interest in mathematics can be traced to childhood in her native Vienna, Austria. Her father was a mathematician, and her mother, a nurse, instilled in her the desire to pursue a career devoted to human betterment. Guided by those instincts, Michor pursued undergraduate programs in both mathematics and molecular biology at the University of Vienna.

In 2002 she joined the evolutionary biology department at Harvard University as a graduate student, where she began studying the evolution of cancer. Michor unraveled, for example, the time required for cancer cells to accumulate mutations in a class of genes that safeguard against cancer. “That seemed like a very straightforward question but … had actually never been addressed before, which is an example of why I was so excited to work in this area,” she says.

One such avenue has helped determine why some patients fail to improve despite short-term treatment with the cancer drug Gleevec, which targets a genetic mutation underlying chronic myeloid leukemia, a life-threatening blood cancer. At just 22, Michor earned a PhD from Harvard University, completing the program in less than three years.

Franziska Michor stands at the foot of a large, wide staircase at a research facility, dressed in a trench coat.

In 2007, Michor began an assistant professorship at Memorial Sloan-Kettering Cancer Center in New York City. There, she used her modeling prowess to solve problems plaguing cancer treatment, focusing on a type of lung cancer, among others.

Michor’s efforts may also someday help brain tumor patients.  Since accepting an associate professorship at Dana-Farber in 2010, Michor has modeled the dynamics of a type of deadly brain tumor called proneural glioblastoma.

 

Awards and Accomplishments

  • Theodosius Dobzhansky Prize of the Society for the Study of Evolution
  • the Alice Hamilton Award
  • the 36th Annual AACR Award for Outstanding Achievement in Cancer Research
Tags
Austria biology biomedical science data regenerative biology stem cell research

Jury Members

2015 Vilcek Prize for Creative Promise in Biomedical Science

Iannis Aifantis

Professor and Chair of the Department of Pathology, New York University School of Medicine

Heran Darwin

Professor of Microbiology, New York University School of Medicine

Laurie Dempsey

Senior Editor, Nature Immunology

Yibin Kang

Warner-Lambert Parke-Davis Professor of Molecular Biology, Princeton University

Peter Palese

Horace W. Goldsmith Professor and Chair of Microbiology, Professor of Medicine, Icahn School of Medicine at Mount Sinai

Leslie Vosshall

Robin Chemers Neustein Professor, The Rockefeller University
Share this page
Twitter Facebook LinkedIn

Related Prize Recipients

Angelika Amon

Angelika Amon (1967-2020) receives the Vilcek Prize in Biomedical Science for groundbreaking research on the molecular signals that regulate cell growth and division, and how errors in these processes contribute to birth defects and cancer.
Portrait of Angelika Amon

Fernando Camargo

Fernando Camargo receives the Vilcek Prize for Creative Promise in Biomedical Science for unraveling the mechanism of blood cell production and uncovering crucial cellular signaling processes implicated in cancer treatment and regenerative medicine.
Portrait of Fernando Camargo

Rob Knight

Rob Knight receives the Vilcek Prize for Creative Promise in Biomedical Science for groundbreaking research on microbial communities and the development of computational tools that honed the analysis of microbial data.
Portrait of Rob Knight

You may also be interested in

February 15, 2022

Harris Wang: Using synthetic biology to understand our world

Wang’s creative and independent thinking has established him as a leader in the field of synthetic biology.
Harris Wang smiling as he walks down a street.
February 1, 2022

Hani Goodarzi: A multidisciplinary approach to cancer biology

Goodarzi’s passion for data science and computational biology has had a profound impact on the field of cancer biology and our understanding of metastasis.
Hani Goodarzi stands in a park with arms folded and smiles.
February 10, 2020

Xiaowei Zhuang: Making the Unseen Seen

Xiaowei Zhuang has pioneered imaging techniques that enable scientists to see the innermost workings of human cells. “The fundamental drive,” she says, “is to figure out how things work.”
Xiaowei Zhuang in a STORM microscopy lab at Harvard University.

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2022   Vilcek Foundation